Coronary Artery Disease (CAD) Clinical Trial
Official title:
Evaluation of a Web-Based Intervention to Promote Physical Activity in Patients With Heart Disease: A Randomize Control Trial
NCT number | NCT00265525 |
Other study ID # | HBR 4855 |
Secondary ID | |
Status | Completed |
Phase | Phase 3 |
First received | |
Last updated | |
Start date | November 2004 |
Est. completion date | August 2007 |
Verified date | March 2022 |
Source | Ottawa Heart Institute Research Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A randomized control trial (RCT) is planned to evaluate a web-based intervention (CardioFit) against usual care in increasing physical activity levels in patients with Coronary Artery Disease (CAD). We hypothesize that compared to usual care, participants in CardioFit will; a) have increased physical activity levels, b) will have a higher health-related quality of life at measurement dates and, c) will have greater improvements in psychosocial predictors.
Status | Completed |
Enrollment | 223 |
Est. completion date | August 2007 |
Est. primary completion date | June 2007 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion Criteria: - Age 20 to 80 years - English Proficiency - Internet Access (home or work) - Documented CAD (most recent cardiac diagnosis); documented Myocardial Infarction (MI), successful PCI procedure Exclusion Criteria: - Patient intends to enroll in structured cardiac rehabilitation - Hospitalization for Coronary Artery Bypass (CABG) - Hospitalization for diagnostic procedure not associated with previously documented MI - Patient coming back to hospital for planned staged PCI within 6 months - Cardiac transplantation - Presence of, or hospitalization for defibrillator implant - Hospitalization for pacemaker implantation - Unresolved unstable angina &/or hospitalization for angina (without MI or PCI) - Uncontrolled arrhythmias causing symptoms or hemodynamic compromise - Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise - Other uncontrolled metabolic conditions (e.g. diabetes) - Chronic infectious diseases such as mononucleosis, hepatitis, AIDS - Acute systematic illness or fever - Uncontrolled tachycardia (<120 bpm) - Uncompensated congestive heart failure (&/or NYHA Class III, or IV) - 3rd degree AV block without pacemaker - Active pericarditis or myocarditis - Recent embolism - Suspected or known AAA aneurysm > 4cm - Uncontrolled hypertension (SBP > 200; DBP > 110) - Pregnancy |
Country | Name | City | State |
---|---|---|---|
Canada | London Health Sciences Centre | London | Ontario |
Canada | Unversity of Ottawa Heart Institute | Ottawa | Ontario |
Lead Sponsor | Collaborator |
---|---|
Ottawa Heart Institute Research Corporation | Heart and Stroke Foundation of Ontario |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Physical activity: measured at baseline (day of hospital discharge), 6 months and 12 months via: | Baseline, 6 and 12 months | ||
Secondary | Measured at baseline, 6 months, and 12 months via follow-up questionnaire: | Baseline, 6 and 12 months | ||
Secondary | Recurrent cardiac events | Baseline, 6 and 12 months | ||
Secondary | Barriers | Baseline, 6 and 12 months | ||
Secondary | Task Self-efficacy | Baseline, 6 and 12 months | ||
Secondary | Outcome expectations | Baseline, 6 and 12 months | ||
Secondary | Social Support | Baseline, 6 and 12 months | ||
Secondary | Perceived environment | Baseline, 6 and 12 months | ||
Secondary | Heart disease specific quality of life | Baseline, 6 and 12 months | ||
Secondary | Use of secondary prevention medications | 6 and 12 months | ||
Secondary | Pedometer (9days) | 6 and 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05292079 -
CAPTURER PMCF Study ( rEPIC04D )
|
||
Recruiting |
NCT05292092 -
Essential Pro PMCF Study ( rEPIC04E )
|
||
Recruiting |
NCT05292014 -
ANGIOLITE PMCF Study ( rEPIC04F )
|
||
Recruiting |
NCT05292118 -
Navitian PMCF Study ( rEPIC04C )
|
||
Completed |
NCT05292105 -
NC Xperience PMCF Study( rEPIC04B)
|
||
Completed |
NCT01435031 -
EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
|
N/A | |
Terminated |
NCT01443754 -
Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease
|
N/A | |
Completed |
NCT00783302 -
Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care
|
N/A | |
Completed |
NCT00543400 -
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
|
Phase 2 | |
Completed |
NCT05516784 -
Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
|
Phase 4 | |
Completed |
NCT02873052 -
MyoVista Measurements in Patients With Atherosclerosis and CAD
|
||
Terminated |
NCT02984891 -
Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
|
||
Completed |
NCT05292144 -
Xperience Pro PMCF Study
|
||
Completed |
NCT02554292 -
Post Market Surveillance of SeQuent Please Neo With Scoring Balloon
|
||
Active, not recruiting |
NCT06052319 -
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
|
||
Completed |
NCT03570697 -
Imaging of Coronary Plaques in Participants Treated With Evolocumab
|
Phase 3 | |
Terminated |
NCT05508893 -
Screening for Coronary Artery Disease USing Primary Evaluation With Coronary CTA in Aviation Medicine (SUSPECT)
|
N/A | |
Completed |
NCT02341664 -
Patient and Provider Assessment of Lipid Management Registry
|
||
Completed |
NCT02098772 -
Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol
|
Phase 3 | |
Recruiting |
NCT05617599 -
SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
|